Skip to main content
Aktis Oncology, Inc. (AKTS)
NASDAQ: AKTS · Real-Time Price · USD
16.28
-0.76 (-4.46%)
Nov 12, 2026, 4:00 PM EST - Market closed

Aktis Oncology Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Net Income
-87.55-63.73-43.98-28.64-17.93
Depreciation & Amortization
3.172.331.581.120.45
Loss (Gain) From Sale of Investments
-4.17-4.62-4.08-3.15-
Stock-Based Compensation
10.795.132.261.480.7
Other Operating Activities
--0.01-0.8-0.2
Change in Accounts Payable
-0.28-0.040.360.66-0
Change in Unearned Revenue
-12.39-5.558.51--
Change in Other Net Operating Assets
4.32.310.11-0.67-1.14
Operating Cash Flow
-86.12-64.1314.76-30-18.13
Operating Cash Flow Growth
-----

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Capital Expenditures
-8.04-9.58-2.86-3.76-2.31
Sale of Property, Plant & Equipment
---0.06-
Investment in Securities
-356.4175.55-187.54-65.12-
Investing Cash Flow
-364.4565.96-190.4-68.83-2.31

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Issuance of Common Stock
341.930.340.18--
Other Financing Activities
-3.29-1.55-1.9--0.15
Financing Cash Flow
338.64-1.21183.28-119.98

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Net Cash Flow
-111.930.637.65-98.8399.55

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Free Cash Flow
-94.16-73.7111.9-33.77-20.43
Free Cash Flow Growth
-----
Free Cash Flow Margin
-760.23%-1134.54%800.27%--
Free Cash Flow Per Share
-2.35-90.6116.90-54.89-39.49
Levered Free Cash Flow
-60.17-36.24-20.08-21.08-
Unlevered Free Cash Flow
-60.17-36.24-20.08-21.08-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Change in Working Capital
-8.36-3.2358.98-0.02-1.14
SEC Filings: 10-K · 10-Q